19-year-old patient with thromboembolism during oral contraception - Familial thrombophilia with heterozygous factor-V Leiden mutation (heterozygous activated protein-C resistance)

被引：0
|
作者：
Pihusch, R [1 ]
deCoutre, P [1 ]
Salat, C [1 ]
Gohring, P [1 ]
Poley, S [1 ]
Hiller, E [1 ]
机构：
[1] UNIV MUNICH,KLINIKUM GROSSHADERN,INST KLIN CHEM,D-8000 MUNICH,GERMANY
来源：
INTERNIST | 1996年 / 37卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1163 / 1166
页数：4
相关论文
共 50 条
  • [31] INCREASED FREQUENCY OF A MUTATION IN COAGULATION FACTOR-V ASSOCIATED WITH RESISTANCE TO ACTIVATED PROTEIN-C IN PATIENTS WITH CORONARY-ARTERY DISEASE
    MARZ, W
    SEYDEWITZ, H
    CHEN, M
    WINCKELMANN, B
    NAUCK, M
    WIELAND, H
    WITT, I
    THROMBOSIS AND HAEMOSTASIS, 1995, 73 (06) : 1374 - 1374
  • [32] PRIMARY ANTIPHOSPHOLIPID SYNDROME IS NOT ASSOCIATED WITH ACTIVATED PROTEIN-C RESISTANCE CAUSED BY FACTOR-V ARG 506-]GLN MUTATION
    BIOUSSE, V
    PIETTE, JC
    FRANCES, C
    BLETRY, O
    PAPO, T
    TOURNIERLASSERVE, E
    DUCHEMIN, J
    AIACH, M
    JOURNAL OF RHEUMATOLOGY, 1995, 22 (06) : 1215 - 1215
  • [33] CO-SEGREGATION OF THROMBOSIS WITH THE FACTOR-V Q506 MUTATION IN AN EXTENDED FAMILY WITH RESISTANCE TO ACTIVATED PROTEIN-C
    BEUFE, S
    BORG, JY
    VASSE, M
    CHARBONNIER, F
    MOREAU, V
    MONCONDUIT, M
    FREBOURG, T
    BRITISH JOURNAL OF HAEMATOLOGY, 1995, 89 (03) : 659 - 662
  • [34] ANALYSIS OF THE FACTOR-V MUTATION ASSOCIATED WITH ACTIVATED PROTEIN-C RESISTANCE AND THROMBOEMBOLIC DISEASE IN SICKLE-CELL PATIENTS WITH STROKE
    WALTER, J
    OHENEFREMPONG, K
    HIGH, KA
    BLOOD, 1994, 84 (10) : A560 - A560
  • [35] The effect of dabigatran and rivarovaban on a prothrombinase-based assay for activated protein C resistance: a preliminary study in subjects heterozygous for factor V Leiden
    Gessoni, Gianluca
    Valverde, Sara
    Gessoni, Francesca
    Valle, Roberto
    BLOOD TRANSFUSION, 2015, 13 (04) : 666 - 668
  • [36] A novel factor V mutation causes a normal activated protein C ratio despite the presence of a heterozygous F5 R506Q (factor V Leiden) mutation
    Prueller, Florian
    Raggam, Reinhard B.
    Mangge, Harald
    Truschnig-Wilders, Martie
    Matzhold, Eva-Maria
    Weiss, Eva-Christine
    Hasiba, Barbara
    Summers, Kelli L.
    Renner, Wilfried
    Siegert, Gabriele
    Kostka, Heike
    BRITISH JOURNAL OF HAEMATOLOGY, 2013, 163 (03) : 414 - 417
  • [37] VARIABILITY OF THROMBOSIS AMONG HOMOZYGOUS SIBLINGS WITH RESISTANCE TO ACTIVATED PROTEIN-C DUE TO AN ARG-]GLN MUTATION IN THE GENE FOR FACTOR-V
    GREENGARD, JS
    EICHINGER, S
    GRIFFIN, JH
    BAUER, KA
    NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (23): : 1559 - 1562
  • [38] Coagulation management of a patient with factor V Leiden mutation, lupus anticoagulant, and activated protein C resistance: a case report
    Stammers, AH
    Dorion, RP
    Trowbridge, C
    Yen, B
    Klayman, M
    Murdock, JD
    Woods, E
    Gilbert, C
    PERFUSION-UK, 2005, 20 (02): : 115 - 120
  • [39] THE POLYMERASE CHAIN-REACTION WITH SEQUENCE-SPECIFIC PRIMERS FOR THE DETECTION OF THE FACTOR-V MUTATION ASSOCIATED WITH ACTIVATED PROTEIN-C RESISTANCE
    KIRSCHBAUM, NE
    FOSTER, PA
    THROMBOSIS AND HAEMOSTASIS, 1995, 74 (03) : 874 - 878
  • [40] IDENTIFICATION OF THE SAME FACTOR-V GENE MUTATION IN 47 OUT OF 50 THROMBOSIS-PRONE FAMILIES WITH INHERITED RESISTANCE TO ACTIVATED PROTEIN-C
    ZOLLER, B
    SVENSSON, PJ
    HE, XH
    DAHLBACK, B
    JOURNAL OF CLINICAL INVESTIGATION, 1994, 94 (06): : 2521 - 2524
12345